Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
B lymphocytes in neuromyelitis optica.
The Impact of Interferon Beta and Natalizumab on Comorbid Migraine in Multiple Sclerosis.
Is metabolic flexibility altered in multiple sclerosis patients?
Differential Cerebellar Functional Interactions during an Interference Task across Multiple Sclerosis Phenotypes.
Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
Efficacy of exercise intervention programs on cognition in people suffering from multiple sclerosis, stroke and Parkinson's disease: A systematic review and meta-analysis of current evidence.
T cell deficiency in spinal cord injury: altered locomotor recovery and whole-genome transcriptional analysis.
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
A case of Guillain-Barré syndrome with meningeal irritation.
General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.
Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases.
A passive exoskeleton can push your life up: application on multiple sclerosis patients.
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US.
2014 multiple sclerosis therapeutic update.
Fingolimod affects gene expression profile associated with LPS-induced memory impairment.
Our products
The history of neuromyelitis optica.
Advanced MRI in multiple sclerosis: current status and future challenges.
[Laquinimod is an oral drug with a marked neuroprotective effect for pathogenetic treatment of multiple sclerosis(review)].
Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options.
The control of reactive oxygen species production by SHP-1 in oligodendrocytes.
Cognitive reserve in multiple sclerosis: Protective effects of education.
Synthesis and biological evaluation of tyrosine modified analogues of the α4β7 integrin inhibitor biotin-R(8)ERY.
CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis.
Pages
« first
‹ previous
…
284
285
286
287
288
289
290
291
292
…
next ›
last »